90-Yttrium-AABD

N/A

Report date: 2025/01/26 19:27:55
NME

Base Information

Drug Name90-Yttrium-AABD
Drug Alias NameRadiotherapeutic (CellSight Technologies/Memorial Sloan Kettering Cancer center/University of California Los Angeles)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellSight Technology, Inc.
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A